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Abstract 
We aimed to elucidate the role of the Ca-independent PKC isoenzyme PKCdelta in the 
regulation of spontaneous in vitro chondrogenesis occurring in a 6-day-long culturing period 
in chicken limb bud-derived high density cell cultures (HDC). PKCdelta expression and 
activity were detectable throughout the entire culturing period with a peak on days 2 and 3, 
when most of the chondroblasts differentiate. To inhibit the activity of PKCdelta, either the 
natural compound rottlerin was transiently applied to the culture medium of HDC in 2.5, 5 or 
10 μM concentrations, or gene silencing was performed by using PKCdelta shRNA. Rottlerin 
significantly reduced the overall PKC activity in enzyme activity assays of cell-free samples 
of untreated control HDC, probably via the inhibition of PKCdelta. On the contrary, we were 
unable to detect any consistent change of PKC enzyme activity assayed in samples of HDC 
treated with rottlerin during culturing. PKCdelta gene silencing resulted in a significantly 
lower PKC activity. Both rottlerin and PKCdelta shRNA caused a severe reduction in 
cartilage formation, furthermore protein and phospho-protein levels of Sox9, the key 
transcription factor of chondrogenesis, were also significantly decreased. Rottlerin lowered, 
while PKCdelta gene silencing elevated the phosphorylation status of ERK1/2. Our data 
suggest that PKCdelta stimulates chondrogenesis via influencing Sox9 and ERK1/2 
phosphorylation, but the inhibition of cartilage formation in the rottlerin-treated HDC is 
probably PKCdelta independent and rottlerin might have different effects when applied to 
cells or to an in vitro enzyme activity assay. 
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List of Abbreviations: BMP, bone morphogenic protein; BSA, bovine serum albumin; CaM-
KIII, calcium/calmodulin dependent protein kinase III; CMF–PBS, calcium/magnesium free 
PBS; DAG, diacyl-glycerol; DMMB, dimethyl-methylene blue; dNTP, deoxy nucleotide 
triphosphate; DTT, 1,4-dithio-threitol; ERK, extracellular signal-regulated kinase; FGF, 
fibroblast growth factor; HDC, high density culture; MAPK, mitogen-activated protein 
kinase; MAPKAP, mitogen-activated protein kinase-activated protein kinase; PAGE, 
polyacrilamide gel electrophoresis; PBS, phosphate buffered saline; PBST, phosphate 
buffered saline and Tween-20; PI, propidium iodide; PKB, protein kinase B; PKC, protein 
kinase C; PMA, phorbol-12-myristate-13-acetate; PMSF, phenylmethylsulphonyl-fluoride; 
PRAK, p38-regulated/ activated protein kinase; RT, reverse transcription; SDS, sodium-
dodecyl-sulphate; TAE, TRIS-acetate-EDTA buffer 
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1. Introduction 
During vertebrate limb development, at the onset of the multistep process of 
endochondral bone formation, undifferentiated chondroprogenitor mesenchymal cells first 
undergo a condensation phase characterised by rapid proliferation of cells. As a result, 
chondrogenic mesenchymal cells become closely packed, which initiates a complex and a yet 
not fully understood signalling mechanism that governs differentiation of cells within these 
condensations into chondroblasts and then mature chondrocytes [1]. Among a number of 
signalling molecules, members of the phospholipid-dependent serine/threonine protein kinase 
C (PKC) family are known regulators of in vitro chondrogenesis [2,3].  
PKCs, present in almost all cell types, are involved in the regulation of various cellular 
processes. All known 11 PKC-isoforms are divided into three subgroups based on their N-
terminal regulatory domains and mechanism of activation: classical PKCs (cPKC; PKCalpha, 
betaI, betaII and gamma), novel PKCs (nPKC; PKCdelta, epsilon, eta and theta) and atypical 
PKCs (aPKC; PKCzeta, iota/lambda and mu or PKD) [4]. The activation of PKCdelta also 
requires lipid second messengers (e.g. DAG) or tumour-promoting phorbol esters (e.g. PMA) 
without the requirement of Ca2+. Moreover, PKCdelta exhibits tyrosine-phosphorylation sites, 
which are targets for Src family kinases. Upon phosphorylation on tyrosine residues, 
PKCdelta can act as a lipid-independent enzyme [5]. One of its distinguishing characteristics 
is that unlike other PKC isoforms, PKCdelta activity is also involved in negative regulation of 
various cellular processes, e.g. suppression of proliferation and survival [6]. PKCdelta is also 
a crucial component of the cellular stress response, since it is required for apoptotic processes, 
however, some data suggest that it can also negatively influence apoptosis [7]. 
To identify the physiological substrates and multiple roles of various PKC-isoenzymes 
in cellular processes, several protein kinase inhibitors have been developed with a variable 
specificity for individual kinases. The bisindolylmaleimide GF109203X is a general PKC 
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inhibitor with a more potent effect on cPKC. The indolocarbazole Gö6976 inhibits both cPKC 
and nPKC [8]. However, the specificity of these pharmacological inhibitors is a rather 
controversial issue [9]. Some protein kinase inhibitors exhibit variable degrees of specificity 
for different enzymes at distinct concentrations. A polyphenolic compound [5,7-dihydroxy-
2,2-dimethyl-6-(2,4,6-trihydroxy-3-methyl-5-acetylbenzyl)-8-cinnamoyl-1,2-chromene], 
rottlerin, isolated from a common Indian rain forest tree, Mallotus philippinensis, is reported 
to inhibit several PKC-isoforms, and is thought to selectively inhibit PKCdelta 5–30-fold 
stronger than other PKCs at 3–6 μM concentration [4]. However, according to the findings of 
an in vitro enzyme activity measurement campaign conducted by the group of Davies [9], in 
which the specificity of various protein kinase inhibitors were assayed, rottlerin was found to 
inhibit many protein kinases (e.g. PRAK, MAPKAP-2) much more potently than PKCdelta, 
and in fact it failed to inhibit in vitro PKCdelta activity. Rottlerin was also described to inhibit 
some other kinases as Akt/PKB and CaM-KIII at 500 nM [10]. Moreover, in a recent review 
analysing data of publications describing controversial results gained by the application of 
rottlerin in order to inhibit PKCdelta, it is concluded that rottlerin can be considered as a 
mitochondrial uncoupler rather than a direct inhibitor of this enzyme [11].  
Rottlerin modulates a great variety of cellular processes in both malignant and non-
malignant cells, including apoptosis in lung cancer, breast cancer, leukaemia and myeloma 
cells, proliferation in glioma cells, secretory activity of pancreatic acinar cells [12-14], and it 
is also known to regulate tumour cell migration [15]. Rottlerin has also been described to 
interfere with the differentiation process of various cell types of mesenchymal origin, exerting 
its effects at least partially by inhibiting the activity of PKCdelta [16-18]. In a recent study, 
Choi and his co-workers reported that rottlerin altered the migration of prechondrogenic 
mesenchymal cells in chicken limb bud high density cultures by modulating integrin β1-
signalling at focal adhesion complexes via a PKCdelta-independent mechanism [10].  
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In this study we applied the same in vitro chondrogenesis model, in which high 
density cell cultures are established from chondrogenic mesenchymal cells isolated from limb 
buds of chicken embryos. In HDC, formation of cartilage starts with the condensation of 
chondroprogenitor mesenchymal cells on the first day, that after nodule formation 
differentiate into chondroblasts and chondrocytes predominantly on the second and third days 
of culturing [19]. Steps of this differentiation process are regulated by numerous growth 
factors and other soluble morphogens [20] and differentiating cells start to secrete cartilage-
specific extracellular matrix components, such as collagen type II and aggrecan on the third 
day of culturing [21]. Expression of cartilage-specific matrix molecules is regulated by Sox9, 
a high-mobility-group domain containing transcription factor, which is started to be expressed 
as soon as mesenchymal cells become committed toward the chondrogenic lineage [22]. 
Detection of the mRNA and protein expression level and the phosphorylation status of Sox9, 
as well as monitoring the expression of the core protein of aggrecan and collagen type II are 
reliable markers of in vitro chondrogenesis. 
Here we provide evidence that PKCdelta is expressed by cells of chondrifying chicken 
limb bud high density cultures throughout their entire differentiation process. Administration 
of rottlerin to cells of HDC resulted in a time and concentration dependent inhibition of 
metachromatic cartilage matrix production and caused a marked decrease in the 
phosphorylation of both Sox9 and ERK1/2, but we failed to unambiguously demonstrate 
inhibition of PKCdelta activity with this compound. PKCdelta gene silencing significantly 
lowered the activity of PKC, abolished cartilage matrix production and decreased the level of 
phosphorylated Sox9, but elevated the phosphorylation of ERK1/2. Our results indicate that 
PKCdelta acts as a positive regulator of in vitro chondrogenesis via modulation of the 
ERK1/2 and Sox9 pathways. Nevertheless, the chondrogenesis-inhibiting effect of rottlerin is 
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probably exerted via a PKCdelta-independent manner, therefore we do not recommend 
administration of rottlerin for PKCdelta inhibition in high density cell culture systems.  
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2. Materials and methods 
2.1. Cell culturing 
Distal parts of the limb buds of Ross hybrid chicken embryos (Hamburger–Hamilton 
stages 22–24) were removed and primary micromass cultures of chondrifying mesenchymal 
cells were established from cell suspensions with a density of 1.5×107 cells/mL. 100–100 L 
droplets of the suspension were inoculated into plastic Petri dishes (Orange Scientifique, 
Braine-l’Alleud, Belgium). Day of inoculation is considered as day 0. After 2 hrs, colonies 
were nourished with Ham’s F12 medium (Sigma, St. Louis, MO, USA), supplemented with 
10% fetal calf serum (Gibco, Gaithersburg, MD, USA) and were kept at 37°C in the presence 
of 5% CO2 and 80% humidity in a CO2 incubator. The medium was changed on every second 
day. 
 
2.2. Transient gene silencing and pharmacologic inhibition of PKCdelta 
PKCdelta shRNA (GenScript USA Inc., Piscataway, NJ, USA) was cloned into 
GeneSwitch™, the inducible protein expression system from Invitrogen (Invitrogen, 
Carlsbad, CA, USA). Plasmids were amplified using competent E. coli bacteria from One 
Shot chemical transformation kit (Invitrogen). Ampicillin or hygromycin resistant bacteria 
were grown on LB agar, and plasmids were isolated using MaxiPrep kit (QIAGEN, Valencia, 
CA, USA) according to the protocol of the manufacturer. Plasmids were delivered into cells 
of chondrifying cell cultures by using Lipofectamine 2000 (Invitrogen) transfection reagent. 
Lipofection delivery system protocol was performed on freshly isolated cell suspensions with 
a density of 1.5×107 cells/mL by decreasing the volume of the transfection reagent by 25%. 
100 or 30 L mixtures of the transfection reagent and cell suspension were inoculated into 
Petri dishes and into 24-well plates, respectively. After 2 hrs of transfection colonies were 
nourished with Ham’s F12 medium supplemented with 10% fetal calf serum. On day 2 of 
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culturing, 1 M mifepristone was added to the culture medium for 24 hrs for the induction of 
GeneSwitch™ System. Activity of PKCdelta was inhibited by applications of 2.5, 5 or 10 μM 
rottlerin (Sigma) for 4 hrs on different days of culturing.  
 
2.3. Light microscopic morphology 
 High-density cultures established from 30 μL droplets of chondrogenic limb bud 
mesenchymal cells of different experimental groups were cultured on the surface of round 
coverglasses (Menzel-Gläser, Menzel GmbH, Braunschweig, Germany) placed into wells of 
24-well culture plates. Cell cultures were fixed in a 4:1 mixture of absolute ethanol and 40% 
formaldehyde on day 6 of culturing and were stained with 0.1% dimethyl-methylene blue 
(DMMB, Aldrich, Germany) dissolved in 3% acetic acid, washed in acetic acid and were 
mounted in gum arabic. The amount of sulphated matrix components was determined with a 
semi-quantitative method, by measuring the optical density of extracted toluidine blue 
(Reanal, Budapest, Hungary) bound to glycosaminoglycans in mature HDC as described 
previously [23]. Briefly, 6-day-old cell cultures were fixed in a solution containing 28% 
ethanol, 4% formalin and 2% acetic acid, stained with 0.1% toluidine blue dissolved in 
glycine-HCl buffer (pH 1.8) for 15 min, and the dye bound to highly sulphated proteoglycans 
and glucosaminoglycans was extracted in 3% HCl dissolved in absolute ethanol. Absorbance 
of samples containing extracted toluidine blue was measured at the wavelength of 625 nm on 
a microplate reader (Chameleon, Hidex Ltd., Turku, Finland). Optical density was measured 
in samples from 3 cultures of each experimental group in 3 independent experiments. Data 
were statistically analysed with Student’s t-test. 
 
2.4. Measurement of cell proliferation with 3H-thymidine labelling and mitochondrial activity 
with MTT-assay 
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15 µL droplets of cell suspension were inoculated into wells of 96-well Wallac LSC 
microtiter plates (PerkinElmer Life and Analytical Sciences, Shelton, CT, USA) and cells 
were treated similarly to those cultured in Petri dishes. Medium containing 1 µCi/mL 3H-
thymidine (185 GBq/mM 3H-thymidine, Amersham Biosciences, Budapest, Hungary) was 
added to the wells for 16 hrs on day 3. After washing with PBS, proteins were precipitated 
with ice-cold 5% trichloroacetic acid, and washed with PBS again. Colonies were air-dried for 
2 weeks at room temperature and radioactivity was counted by Chameleon liquid scintillation 
counter (Hidex). Measurements were carried out in 10 samples of each experimental group in 
4 independent experiments. For investigation of cellular viability, cells cultured in wells of 
96-well microtiter plates were used. 10 µL MTT reagent [3-(4,5-dimethyl-thiazolyl-2)-2,5-
diphenyltetrazolium bromide; 25 mg MTT in 5 mL PBS] was pipetted into each well on day 
3. Cells were incubated for 2 hrs at 37°C and following addition of 100 µL of MTT 
solubilizing solution the absorption was detected at 570 nm using a Chameleon microplate 
reader (Hidex). 
 
2.5. Measurement of apoptosis and necrosis by flow cytometry 
 After 24 hrs of transfection or treatments with rottlerin, rate of apoptosis was 
measured by using AnnexinV DY 647 kit (Central European Biosystems, Budapest, 
Hungary). Mock-transfected cells (cultures treated only with the transfection reagent) or 
untreated cultures were used as control. After washing twice in CMF–PBS (calcium and 
magnesium free phosphate buffered saline), cells were incubated with 10 L AnnexinV DY 
647 at room temperature for 10 min. Before harvesting with 0.25% trypsin (Sigma) cells were 
washed with Annexin binding buffer. Necrosis was measured by using propidium-iodide (PI, 
Invitrogen). Cells were washed in CMF–PBS and 2 L PI was added at room temperature for 
10 min in a dark chamber. Cell pellets were resuspended in 500 L FACS buffer (PBS 
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supplemented with 1% BSA and 0.05% NaN3) and measured on a CyFlow
® space Flow 
Cytometer (Partec GmbH, Münster, Germany). PI was monitored at 617 nm and Annexin 
DY647 at 670 nm. Measurement lower threshold was set on cell-size particles. Analysis was 
performed with WinMDI 2.8 freeware (Joseph Trotter; http://facs.scripps.edu/).  
 
2.6. Preparation of cell extracts 
 Chondrifying cell cultures were washed with physiological NaCl solution and were 
harvested on different days of culturing. After centrifugation cell pellets were suspended in 
100 L of a homogenization buffer containing 50 mM Tris-HCl buffer (pH 7.0), 0.5 mM 1,4-
dithio-threitol (DTT), 10 μg/mL Gordox, 10 μg/mL leupeptin, 1 mM phenylmethylsulphonyl-
fluoride (PMSF), 5 mM benzamidine, 10 μg/mL trypsin inhibitor as protease inhibitors, and 
0.5% Triton X-100. Samples were snap-frozen in liquid nitrogen, then stored at –70°C. 
Suspensions were sonicated by pulsing burst for three times 30 sec by 50 cycles (Cole Palmer 
Ultrasonic distributor, Illinois, USA). For Western blotting and for PKCdelta activity assays, 
total cell lysates were used. For RT-PCR analysis, cartilage colonies were washed three times 
with RNase-free physiological NaCl, then the cultures were stored at –70°C. 
 
2.7. RT-PCR analysis 
Cell cultures were dissolved in Trizol (Applied BioSystems), 20% RNase-free chloroform 
was added and the samples were centrifuged at 4°C at 10,000 ×g for 15 min. Samples were 
incubated in 500 µL of RNase-free 2-propanol in –20°C for 1 h, total RNA was harvested in 
RNase-free water and stored at –20°C. The assay mixture for reverse transcriptase reaction 
contained 2 µg RNA, 0.112 µM oligo(dT), 0.5 mM dNTP, 200 units M-MLV RT in 1× RT 
buffer. The sequences of primer pairs for polymerase chain reaction were as follows: for 
chicken PKCdelta (accession number: NM_001006133): 5’–CTG AGG TGA CCG TGG 
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GTG T–3’ and 5’–TTG TGG ATG GCA GCG TTA–3’; for chicken aggrecan (accession 
number: XM_001232949): 5’–CAA TGC AGA GTA CAG AGA–3’ and 5’–TCT GTC TCA 
CGG ACA CCG–3’; for chicken Sox9 (accession number: AB012236): 5’–CCC CAA CGC 
CAT CTT CAA–3’ and 5’–CTG CTG ATG CCG TAG GTA–3’; for chicken ERK1/2 
(accession number: NM_204150): 5’–CAC CTC AGC AAC GAC CAC–3’ and 5’–AGG 
AGC CCT GTA CCA ACG–3’; and for chicken GAPDH (accession number: NM_204305): 
5’–GAG AAC GGG AAA CTT GTC AT–3’ and 5’–GGC AGG TCA GGT CAA CAA–3’. 
Amplifications were performed in a programmable thermocycler (PCR Express Temperature 
Cycling System, Hybaid, UK) as follows: 94C, 1 min, followed by 30 cycles (94C, 30 sec, 
54C, 30 sec, 72C, 30 sec) and then 72C, 5 min. After the addition of 1/5 volume of fivefold 
concentrated DNA sample buffer (0.41% bromophenol blue, 66.6% sucrose in TAE buffer 
containing 0.016 M EDTA, 0.19 M acetic acid and 0.4 M Tris-HCl; pH 8.5) PCR products 
were analysed by electrophoresis in 1.2% agarose gel containing ethidium bromide. Optical 
density of signals was measured by using ImageJ 1.40g freeware and results were normalised 
to the optical density of untreated control cultures. 
 
2.8. Western blot analysis 
 Total cell lysates were examined by Western blot. Samples for SDS-PAGE were 
prepared by adding 1/5 volume of fivefold concentrated electrophoresis sample buffer (310 
mM Tris–HCl pH 6.8, 10% SDS, 50% glycerol, 100 mM DTT, 0.01% bromophenol blue) to 
cell lysates and boiled for 10 min. About 70–80 g of protein was separated by 10% SDS-
PAGE gel for detection of PKCdelta, Sox9, p-Sox9, ERK1/2 and p-ERK1/2. Proteins were 
transferred electrophoretically to nitrocellulose membranes. After blocking in 5% non-fat dry 
milk in PBST (phosphate buffered saline with 0.1% Tween 20; 20 mM Na2HPO4, 115 mM 
NaCl; pH 7.4), membranes were washed and exposed to the primary antibodies overnight at 
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4C. Polyclonal anti-PKCdelta antibody (Santa Cruz Inc., CA, USA) in 1:100, polyclonal 
anti-Sox9 antibody (Abcam, Cambridge, UK) in 1:600, polyclonal anti-p-Sox9 antibody 
(Sigma) in 1:600, polyclonal anti-ERK1/2 antibody (Sigma) in 1:1000, and polyclonal anti-
MAP kinase (diphosphorylated ERK1/2 on Thr and Tyr residues; Sigma) in 1:600 dilution 
were used. After washing three times for 10 min with PBST, membranes were incubated with 
the secondary antibody, anti-rabbit IgG (Bio-Rad Laboratories, CA, USA) in 1:1000 dilution 
in PBST containing 1% non-fat dry milk for 2 hrs at room temperature. Signals were detected 
by enhanced chemiluminescence (Millipore, Billerica, MA, USA) according to the 
instructions of the manufacturer. Optical density of signals was measured by using ImageJ 
1.40g freeware (downloaded from: http://rsb.info.nih.gov/ij/) and results were normalised to 
the optical density of untreated control cultures. 
 
2.9. Total PKC and PKCdelta enzyme activity measurements 
For PKC activity assays, cells were harvested and after centrifugation at 10,000×g for 
10 min at 4°C, supernatants were used for enzyme activity measurements. PKC activity was 
assayed by measuring the incorporation of 32P from [γ-32P]-ATP (MP Biomedicals, Solon, 
OH, USA) into histone IIIS (Sigma). The reaction mixture (40 µL) contained 50 mM Tris 
HCl buffer (pH 7.5), 1 mg/mL histone IIIS, 0.8 mM CaCl2, 0.5 mM DTT, 1 µg/mL Gordox, 1 
µg/mL leupeptin, 0.1 mM PMSF, 0.5 mM benzamidine, 1 µg/mL trypsin inhibitor as protease 
inhibitors, 100 µg/mL phosphatidylserine, 4 µg/mL PMA (Sigma), 0.12 mM ATP, 6 mM Mg-
acetate and [γ-32P]-ATP adjusted to approximately 1 million cpm/reaction mixture and 
appropriate amount of cell extract (2.0–2.5 mg/mL protein). Activity measurements were 
performed at 30°C. Determination of 32P incorporation into histone IIIS were carried out by 
pipetting 30 µL of the reaction mixture on filter paper squares (Whatman P81, 2×2 cm) after 
20 min reaction time. All papers were washed three times in 0.5% phosphoric acid, dried and 
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counted for radioactivity in a liquid scintillation counter. For measurements of PKCdelta 
activity, rottlerin (10 μM) was administered to the reaction mixtures, and the difference 
caused by this compound in the total PKC activity was considered to be the contribution of 
PKCdelta to the overall PKC activity. 
 
2.10. Data processing and statistical analysis 
To determine the metachromatic cartilage matrix production, optical density of 
toluidine blue-stained cultures (OD625 nm) was measured in samples from 3 cultures of each 
experimental group in 3 independent experiments. For the detection of cellular proliferation 
rate (3H–thymidine incorporation assay) or mitochondrial activity (MTT assay), 
measurements were carried out in 10 samples of each experimental group in 4 independent 
experiments. Data are mean values ± standard error of the mean and were statistically 
analysed with Student’s t-test (P < 0.01). Data analysis of FACS measurement results was 
performed with WinMDI 2.8 freeware (Joseph Trotter; http://facs.scripps.edu/). For RT-PCR 
reactions and Western blot analyses, optical density of signals was measured by using ImageJ 
1.40g freeware and results were normalised to the optical density of untreated control 
cultures. Data of PKC enzyme activity measurements were statistically analysed with 
Student’s t-test (P < 0.01). 
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3. Results 
3.1. PKCdelta expression and activity in cells of HDC 
To identify the mRNA and protein expression pattern of PKCdelta during in vitro 
chondrogenic differentiation of chicken mesenchymal cells, RT-PCR reactions and Western 
blot analyses were performed, respectively. The mRNA sequence of chicken PKCdelta was 
downloaded from GenBank and a specific primer pair was designed for amplification. 
mRNA expression of chicken PKCdelta in cells of HDC followed an unchanged pattern 
during differentiation from day 0, with only slightly higher expression levels on days 1 and 2 
(Fig. 1A). The protein expression profile of chicken PKCdelta, however, followed a peak-like 
pattern and showed an almost four-fold elevation by days 2 and 3 compared to day 0, as 
revealed by Western blot analyses (Fig. 1B). Under control conditions, the enzyme activity of 
PKCdelta in cells of HCD exhibited a pattern that is closely correlated with the protein 
expression, i.e. the enzyme activity was higher on days 1–4 compared to day 0. Activity of 
PKCdelta then decreased toward the end of the culturing period (Fig. 1C). 
 
3.2. Rottlerin inhibits in vitro chondrogenesis in a time and concentration-dependent manner 
To identify the effects of rottlerin on cartilage differentiation in vitro, rottlerin at 
concentrations of 2.5 and 5 μM was administered to cells of HDC on various days of 
culturing. Cartilage matrix production was analysed by metachromatic staining procedures 
with dimethyl-methylene blue and toluidine blue on day 6 of culturing. As seen in Fig. 2A, 5 
μM rottlerin inhibited in vitro chondrogenesis in a time- and concentration-dependent manner 
with the strongest inhibition on days 2 and 3 (12% of untreated control cultures). When 
rottlerin was administered in 10 μM or higher concentrations on either day of culturing, 
cartilage matrix production was completely blocked as demonstrated by the complete loss of 
metachromatic staining. Because treatments by either 2.5 or 5 μM rottlerin resulted in similar 
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qualitative results, in the following set of experiments we only used the concentration of 5 
μM. 
Since the observed decrease in metachromatic staining could have been caused by 
cytotoxic and/or anti-proliferative effects of rottlerin, mitochondrial activity and cellular 
proliferation assays were performed, respectively. Rottlerin administered on days 2 and 3 for 
4 hrs in 5 μM concentration caused a slight, but significant decrease in metabolic activity in 
cells of HDC and it also caused a significant decrease in proliferation rate as revealed by 
MTT and radioactively labelled thymidine incorporation assays, respectively (Fig. 2B). 
Rottlerin treatments did not result in the elevation of apoptotic or necrotic rate in cells of 
HDC in either concentration according to FACS analyses (data are shown in the Supporting 
information). 
To evaluate the role of rottlerin in the molecular regulation of in vitro chondrogenesis, 
mRNA and protein levels of PKCdelta, aggrecan core protein and Sox9, the major cartilage-
specific transcription factor, were detected by RT-PCR and Western blot reactions, 
respectively. Exposure to rottlerin resulted in a marked decrease in the mRNA expression of 
PKCdelta (Fig. 3A), however, only a slight reduction was observed in its protein expression 
level when rottlerin was applied at a concentration of 5 μM (Fig. 3B). A significant decrease 
in the mRNA levels of both aggrecan core protein and Sox9 was detected under the effect of 
rottlerin treatments (Fig. 3A). Western blot analyses showed that exposure to 5 μM rottlerin 
only slightly reduced the protein level of Sox9, whereas a significant decrease was observed 
in its phosphorylation level after the administration of the inhibitor (Fig. 3B). These findings 
demonstrate that rottlerin decreases cartilage formation, at least partly, via inhibition of 
cartilage differentiation. 
Since MAP-kinases, particularly ERK1/2 is one of the key regulators that influence in 
vitro chondrogenesis, we examined whether the observed decrease in cartilage matrix 
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production was regulated by an ERK1/2 dependent pathway. Although administration of 
rottlerin did not alter the mRNA expression level of ERK1/2 and protein expression was also 
only slightly modified, exposure to 5 μM rottlerin significantly reduced the level of 
phosphorylated ERK1/2 (Fig. 3A–B). Furthermore, administration of 5 μM rottlerin to cells 
on days 2 and 3 caused alterations in the activity of PKCdelta measured on day 3 of culturing 
in cell-free extracts of HDC, but the direction of these changes was completely inconsistent 
(data not shown). These findings suggest that the aforementioned effects of rottlerin on 
cartilage differentiation could have mostly been caused by its aspecific, non-PKCdelta-
dependent effects. 
 
3.3. Inhibition of PKCdelta by shRNA transfection inhibits in vitro chondrogenesis 
Although rottlerin is widely known as a selective inhibitor of PKCdelta, some data are 
available on its PKCdelta-independent effects [24] and our results also suggested such a 
possibility. Therefore, we selectively inhibited PKCdelta expression using specifically 
designed shRNA to clarify the role of PKCdelta in chondrogenesis. The PKCdelta shRNA 
sequence was cloned into GeneSwitch, the inducible protein expression system from 
Invitrogen, and transfected into primary chondroprogenitor mesenchymal cells on day 0, prior 
to their attachment by using Lipofectamine 2000 transfection reagent. On day 2 of culturing, 1 
M mifepristone was added to the culture medium for 24 hrs for the induction of GeneSwitch 
System. Mifepristone at the applied concentration did not alter the amount of in vitro cartilage 
matrix production by culturing day 6 (data are shown in the Supporting information). 
Introduction of empty GeneSwitch vector alone into cells of HDC resulted in a 
significant decrease of metachromatic cartilage matrix production (40% of mock-transfected 
control cultures) as revealed by dimethyl-methylene blue and toluidine blue staining 
procedures on day 6 of culturing (Fig. 4A). Introduction of PKCdelta shRNA containing 
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GeneSwitch resulted in an even stronger inhibition (5% of mock-transfected control cultures), 
and the complete loss of the metachromatic cartilage matrix (Fig. 4A). 
In spite of the pronounced inhibition of cartilage matrix production, mitochondrial 
activity of cells transfected with either empty or PKCdelta shRNA containing GeneSwitch 
constructs remained unchanged compared to mock-transfected control cells as revealed by 
MTT assays, and the rate of cellular proliferation also did not show any alterations in either 
case (Fig. 4B). Cellular viability and apoptosis assays performed by measuring the ratio of 
propidium iodide and Annexin V DY647 stained cells using FACS analysis revealed that 
transfection with the empty vector did not cause any change in these parameters, whereas 
introduction of the PKCdelta shRNA vector resulted in a very slight elevation of apoptotic 
(2%) and necrotic (1%) cell death (Fig. 4C). These findings demonstrate that the observed 
decrease in cartilage matrix production was not caused by altered cellular viability, 
mitochondrial activity, proliferation or apoptotic rate. 
We also wanted to examine the signalling mechanism underlying the aforementioned 
alterations of in vitro cartilage matrix production. To evaluate the efficiency of gene silencing, 
RT-PCR and Western blot analyses were performed. Although mRNA expression of 
PKCdelta decreased only to a lesser extent as a result of shRNA expression (Fig. 5A), 
however, at the protein level it exhibited a marked inhibition (30% of cultures transfected 
with the empty vector) reflecting on the efficiency of PKCdelta gene silencing (Fig. 5B). 
While PKCdelta gene silencing did not change the mRNA-expression of sox9, and the mRNA 
level of aggrecan core protein only exhibited slight alterations, the protein level of Sox9 
showed a marked decrease as a result of introduction of PKCdelta shRNA, as revealed by RT-
PCR and Western blot analyses, respectively (Fig. 5A–B). Although PKCdelta gene silencing 
did not affect either the mRNA or the protein expression of ERK1/2, a significant (two-fold) 
increase in its phosphorylated form was observed, implicating the involvement of this 
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pathway in the signal transduction mechanism of PKCdelta in cells of chondrifying 
micromass cultures. Administration of either the empty or the PKCdelta shRNA-containing 
vector resulted in a significant decrease in PKC activity of cells in HDC, with a more than 
50% reduction in cultures transfected with PKCdelta shRNA (Fig. 5C) as compared to mock-
transfected cultures.  
 
3.4. Protein expression and phosphorylation status profiles of Sox9 and ERK1/2 exhibit a 
time-dependent pattern in differentiating HDC 
Since both the cartilage-specific transcription factor Sox9 and the dual-specificity 
MAPK ERK1/2 are key regulators of in vitro chondrogenesis, and their activity can be 
modified by reversible phosphorylation, we examined their protein expression as well as the 
phosphorylation status pattern in untreated control cultures during the 6-day-long culturing 
period. As shown in Fig. 6, the protein expression profiles of ERK1/2 and its dual 
phosphorylated (fully active) form demonstrate that the activity of ERK1/2 is the highest in 
young chondroblasts (i.e. in cells of 3-day-old HDC) and becomes lower in differentiated 
chondrocytes (6-day-old HDC). Although Sox9 is readily expressed in chondroprogenitor 
mesenchymal cells (0-day-old HDC), we detected a 5-fold elevation in 2-day-old cultures, 
when the cells start their differentiation programme. In differentiated cultures, Sox9 
expression shows a decrease, but it does not reach the baseline level again. Changes in the 
phosphorylation level of Sox9 are not significant, nonetheless, it exhibits a similar pattern 
(Fig. 6).
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4. Discussion 
It has long been known that various PKC isoenzymes are involved in the chondrogenic 
differentiation of chicken limb micromass cultures. PKC enzyme activity proved to be 
detectable in cells of HDC with characteristic changes during differentiation, and conversely, 
exposure of cultures to long-term phorbol-12-myristate-13-acetate (PMA) treatments blocked 
the differentiation process and abolished in vitro cartilage matrix production [25]. In a study 
conducted by Choi and his colleagues the expression profiles of classic (PKCalpha and 
gamma), novel (PKCepsilon) and atypical (PKCzeta, lambda and iota) protein kinase C 
isoenzymes have been described during the differentiation of chicken micromass cultures and 
they showed that expression of various cPKC and nPKC isoforms is mostly required at the 
early stages of in vitro cartilage formation [3]. However, Choi and his group failed to detect 
PKCdelta expression in cells of HDC with the antibodies employed [3]. It has also been 
reported that protein kinase A signalling regulates in vitro chondrogenesis of chicken 
mesenchymal cells via the PKCalpha pathway [26]. PKCdelta expression in cells of HDC was 
reported for the first time by Grill and his colleagues, who confirmed its protein expression by 
immunochemical and immunocytochemical approaches [27]. Recently, Choi and his 
colleagues demonstrated the protein expression of PKCdelta by Western blot analyses in cells 
of HDC [10], when they investigated the involvement of this signal molecule in the regulation 
of the formation of prechondrogenic nodules. Consistent with their data, our results also 
showed a marked increase in PKCdelta protein expression at the beginning of the 6-day-long 
culturing period, followed by a decrease in its expression level. We also confirmed these 
findings by PKCdelta enzyme activity assays, with the maximum levels of activity 
corresponding to the highest levels of protein expression on culturing days 1 to 4. 
Correspondence of these patterns to the onset of chondrogenic differentiation of cells in HDC 
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supports our idea that PKCdelta is a good candidate among PKC isoforms to be involved in 
the regulation of signalling mechanisms leading to in vitro cartilage formation.   
In the subsequent set of experiments rottlerin (mallotoxin), described as an inhibitor of 
PKCdelta activity in some publications [28-30], was administered to cells of HDC. Rottlerin 
treatments resulted in a decrease of cartilage matrix production in a concentration and time 
dependent manner, including days 1 or 2 of culturing, when condensation and nodule 
formation of chondrogenic mesenchymal cells take place. These results are in agreement with 
the findings of Choi and his colleagues, who reported that rottlerin, via modulation of Akt-
signalling and integrin β1-mediated pathways, might be negatively involved in the regulation 
of the migratory potential of chondroprogenitor cells in chicken limb bud-derived HDC, but 
in a PKCdelta-independent manner [10].  
Since the decrease in metachromatic cartilage matrix production we observed might 
have resulted from the reduced cellular viability and/or decreased cellular proliferation rate, 
mitochondrial oxidase activity (MTT) and proliferation (radioactively labelled thymidine 
incorporation) assays were performed. While the cellular viability was only lowered to a 
lesser, but still significant extent, a more pronounced decrease in the rate of proliferation was 
observed. The latter result is consistent with the antiproliferative effect of rottlerin on HaCaT 
keratinocytes [24]. Administration of rottlerin did not induce either apoptosis or necrosis in 
cells of HDC. As rottlerin is described as a mitochondrial uncoupler of different mammalian 
cell types rather than a direct PKCdelta inhibitor in some recent publications [11,31], these 
findings may reflect on a difference in mitochondrial sensitivity to rottlerin of chicken 
compared to mammalian cells. mRNA and protein expression of sox9, the key chondrogenic 
transcription factor decreased after rottlerin treatments, moreover, phosphorylation of Sox9 
(resulting in a more active form of this transcription factor) was almost completely abolished. 
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The observed decrease in the phosphorylated form of Sox9 protein could be, at least partially, 
accounted for the reduced cartilage matrix production after the administration of rottlerin.  
The ERK pathway, also known as the MEK-ERK kinase cascade, is one of the key 
cytoplasmic signal transduction pathways governing proliferation, survival and differentiation 
of eukaryotic cells. The role of this crucial signal pathway in the regulation of chondrogenesis 
is rather controversial and probably depends either on the experimental model or/and the 
methods applied. ERK1/2 was reported as a negative regulator of chondrogenesis in both 
HDC [32,33] and C3H10T mouse embryonic mesenchymal cells [34]. In these experiments 
the function of ERK1/2 was assessed by the application of pharmacological inhibitors 
PD098059 or U0126 [35]. On the contrary, it seemed to promote chondrogenesis in adult 
human bone marrow derived multipotent progenitor cells when the gene silencing technique 
was the approach [36]. Nonetheless, we found that the protein expression profiles of ERK1/2 
and its dual phosphorylated (fully active) form show that the activity of ERK1/2 is the highest 
in young chondroblasts (i.e. in cells of 3-day-old HDC) and becomes lower in differentiated 
chondrocytes (i.e. 6-day-old HDC) (Fig. 6). In our current experiments neither the mRNA, 
nor the protein expression of ERK1/2 was altered after treatments with rottlerin, but its 
phosphorylated form was almost completely diminished. Our results correspond with that of 
another study conducted by Tapia and his colleagues on pancreatic acinar cells, where 
rottlerin also proved to inhibit MAPK-activation [14].  
Since rottlerin has been described as a factor having both PKCdelta dependent and 
independent effects often leading to contradictory results on various tissue and cell types 
[14,24], we were prompted to apply targeted PKCdelta mRNA silencing to clarify the role of 
PKCdelta activity during the differentiation of chondrogenic mesenchymal cells. Transfection 
with PKCdelta shRNA and subsequent transient gene silencing of cellular PKCdelta almost 
completely blocked in vitro chondrogenesis. Neither mitochondrial activity, nor cellular 
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proliferation rate were significantly affected by the introduction of either the empty or the 
PKCdelta shRNA-containing vectors into cells of HDC, furthermore, PKCdelta gene 
silencing did not induce significant apoptotic and/or necrotic cell death rate of chondrogenic 
cells. In contrast to our results, PKCdelta has been reported as an accelerator of proliferation 
in cultured human skeletal muscle cells and C2C12 myoblast cells during myogenic 
differentiation, although the authors applied rottlerin to investigate the effects of the inhibition 
of PKCdelta in these experiments [37]. In our experiments, administration of either the empty 
or the PKCdelta shRNA-containing vector into cells of HDC caused a significant decrease in 
PKC activity assayed on day 3. The approximately 70% decrease in PKC activity values 
detected in HDC transfected with the shRNA-containing vector may reflect on the fact that 
reduction of the efficacy of chondrogenesis itself could have led to an inhibition of PKC 
activity. Another possibility is that PKCdelta might be involved in the regulation of the 
activity of other members of the PKC family. This idea is based on the theory of Toker, who 
proposed that some PKC isoenzymes can activate other PKCs via phosphorylation in a 
cascade-like manner [38].  
Since PKCdelta gene silencing effectively decreased PKC enzymatic activity and led 
to an almost complete inhibition of in vitro cartilage matrix production, the expression of the 
molecular regulators of chondrogenesis was also investigated. While the mRNA expression of 
sox9 was not affected, its protein expression and phosphorylation were markedly reduced as a 
result of the introduction of PKCdelta shRNA, and this reduction can partially be accounted 
for the observed effects on metachromatic cartilage matrix production. Inhibition of PKCdelta 
activity in osteoblasts by using siRNA has led to a decrease in the phosphorylation and 
activity of ERK1/2, which in turn has suppressed the differentiation of diosmetin-induced 
differentiation of these cells [39]. On the contrary, activation of PKCdelta was found to 
decrease the activity of ERK1/2 in keratinocytes [40].  Moreover, PKCdelta altered 
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differently the phosphorylation of ERK1/2 in human primary skeletal muscle cells and C2C12 
rat myogenic cells [37]. Although neither the mRNA nor the protein expression of ERK1/2 
showed any alterations as a result of PKCdelta gene silencing in our experimental system, the 
level of its phosphorylated form exhibited a two-fold increase. If the observation that younger 
chondroblasts have the highest ERK activity in HDC is taken into consideration, it seems to 
be plausible to conclude that the persistently elevated ERK1/2 activity may block further 
differentiation of chondroblasts and in this way could be a factor involved in the complete 
inhibition of in vitro cartilage matrix production following PKCdelta gene silencing. 
However, application of gene silencing of PKCdelta had variable effects on MEK-ERK1/2 
signalling pathway in different systems [39,41,42], but the majority of the investigations 
describes PKCdelta as a negative regulator of  MEK-ERK1/2 pathway [43]. As we failed to 
detect any elevation in the phosphorylation of ERK1/2, instead, we found a decreasing pattern 
following the application of rottlerin, therefore we suppose that this compound is probably not 
a PKCdelta inhibitor in HDC. This idea is further supported by the fact that we were unable to 
detect any consistent change of PKCdelta enzyme activity in our experiments when rottlerin 
was applied to the culture medium of cells for 4–4 hrs on days 2 and 3. However, when 
rottlerin was added to the reaction mixtures of total PKC enzyme activity assays performed in 
cell free samples prepared from untreated HDC, it resulted in significantly lower enzyme 
activities. Nonetheless, the contradiction can be resolved if we hypothesise that rottlerin might 
have different effects when applied to cells or to an in vitro enzyme activity assay. As we 
have already mentioned, rottlerin has been described as a mitochondrial uncoupler in different 
cells [11], and a wide range of its effects (including indirect inhibition of PKCdelta) can be 
regarded as a consequence of this phenomenon. 
Taken together, our results suggest that PKCdelta is a positive regulator of in vitro 
chondrogenesis upstream to the protein expression and phosphorylation of Sox9. Since the 
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activity of ERK1/2 was increased by PKCdelta gene silencing, PKCdelta could also be a 
negative regulator of the ERK1/2 kinase pathway in HDC. However, our results concerning 
the involvement of PKCdelta in the MAPK pathway seem to be controversial, as inhibition of 
PKCdelta activity by rottlerin and PKCdelta gene silencing has led to opposing results. 
Nevertheless, the apparent confusion can be resolved if the PKCdelta-independent effects of 
rottlerin are also taken into consideration: rottlerin is reported to inhibit other PKC isoforms 
as well as other kinases, such as p38-regulated kinase, MAPK-activated protein kinase 2, 
PKA or CaM-KIII and it can also modulate mitochondrial metabolic processes [11,14]. 
Because of its diverse and probably non-PKCdelta-specific effects, we do not recommend 
application of rottlerin as an approach for investigating the role of PKCdelta in chondrifying 
high density micromass cultures. 
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5. Conclusions 
The main findings of this work can be summarised as follows. The continuously 
detectable PKCdelta expression and activity exhibited a peak on days 2 and 3, when 
chondrogenic cells differentiate into chondroblasts in HDC. Rottlerin decreased PKC activity 
in a cell-free assay system, but failed to inhibit PKC activity when it was applied to HDC 
during culturing. Gene silencing resulted in a significantly lower PKC activity. Both rottlerin 
and PKCdelta shRNA caused a severe reduction in cartilage formation as well as in the 
protein and phospho-protein levels of Sox9. Rottlerin reduced, while PKCdelta gene silencing 
elevated the phosphorylation status of ERK1/2. On the basis of our results, we concluded that 
PKCdelta stimulates in vitro chondrogenesis via influencing Sox9 and ERK1/2 
phosphorylation, but inhibition of cartilage formation in the rottlerin-treated HDC is 
presumably a PKCdelta independent process. 
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Figure 1. mRNA (A) and protein (B) expression of PKCdelta in cells of chondrifying 
micromass cultures  on various days of culturing. For RT-PCR reactions, GAPDH was used 
as a control. Optical density of signals was measured and results were normalised to the 
optical density of 0-day-old cultures. Representative data of 3 independent experiments. Total 
PKC and PKCdelta enzyme activity (C) in cells of HDC on various days of culturing. The 
white upper part of each bar represents the contribution of PKCdelta enzyme activity (i.e. 
difference caused by rottlerin in cell-free extracts) to total PKC enzyme activity, whereas the 
black lower parts represent the activity of other PKC isoforms. Significant changes are 
indicated by * and # (P < 0.01) as an increase or decrease in total PKC (#) and PKCdelta (*) 
enzyme activity as compared to the respective control (day 0). Representative data of 3 
independent experiments. 
 37 
 
 
 38 
 
Figure 2. Effect of rottlerin on cartilage matrix production of high density micromass cultures 
on various days of culturing (A). Metachromatic cartilage areas in 6-day-old high-density 
colonies visualised with DMMB dissolved in 3% acetic acid. Optical density (OD625) of 
samples containing toluidine blue extracted with 8% HCl dissolved in absolute ethanol. Data 
are mean values ± standard error of the mean (± 6%) of each experimental group out of 10 
measurements. Effects of rottlerin treatment (5 μM) on the mitochondrial activity and cellular 
proliferation (B) of cells in 3-day-old HDC. Mitochondrial activity was measured by using 
MTT assay and cell proliferation was assessed by 3H-thymidine incorporation. Assays were 
carried out immediately after rottlerin treatments. Asterisks indicate significant (*P < 0.01) 
decrease in metachromatic cartilage matrix production, mitochondrial activity or cellular 
proliferation rate as compared to the respective control (day 3). Representative data of 3 
independent experiments. 
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Figure 3. Effect of 5 μM rottlerin treatment on the mRNA expression of PKCdelta, aggrecan, 
Sox9 transcription factor and ERK1/2 (A); the protein expression of PKCdelta and ERK1/2; 
the protein expression and phosphorylation of Sox9 (B) in HDC on day 3 of culturing. For 
RT-PCR reactions GAPDH was used as a control. Optical density of signals was measured 
and results were normalised to the optical density of respective control cultures. 
Representative data of 3 independent experiments.  
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Figure 4. Effect of PKCdelta gene silencing on cartilage matrix production in high density 
micromass cultures (A). Metachromatic cartilage areas in 6-day-old high-density colonies 
 41 
 
visualised with DMMB dissolved in 3% acetic acid. Optical density (OD625) of samples 
containing toluidine blue extracted with 8% HCl dissolved in absolute ethanol. Data shown 
are mean values ± standard error of the mean (± 5%) of each experimental group out of 10 
measurements. Asterisk indicates significant (*P < 0.01) decrease in optical density of 
extracted toluidine blue as compared to the respective control (mock-transfected cultures). 
Effects of PKCdelta gene silencing on mitochondrial activity and cellular proliferation (B) of 
cells in 3-day-old HDC. Empty columns represent mitochondrial activity and cellular 
proliferation rate of cultures transfected with the empty vector (GeneSwitch), gray columns 
represent mitochondrial activity and cellular proliferation of HDC transfected with the 
PKCdelta shRNA-containing vector. Mitochondrial activity was measured by MTT assay and 
cell proliferation was assessed by 3H-thymidine incorporation. Effect of PKCdelta gene 
silencing on apoptotic rate and cellular viability of cells in 3-day-old HDC (C). Cellular 
viability was determined by FACS analysis. Quadrants 1 and 2 represent cells stained by 
Annexin V DY 647 (i.e. cells undergoing apoptosis), whereas quadrants 2 and 3 represent 
cells containing propidium-iodide (i.e. dead cells) of various sizes. For panels (A), (B) and 
(C) cultures treated with the transfection reagent (Lipofectamine 2000) were used as controls. 
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Figure 5. Effect of PKCdelta gene silencing on the mRNA expression of PKCdelta, aggrecan 
and Sox9 transcription factor (A); protein expression of PKCdelta; protein expression and 
phosphorylation of Sox9 and ERK1/2 (B) in 3-day-old HDC. For RT-PCR reactions, GAPDH 
was used as a control. Optical density of signals was measured and results were normalised to 
the optical density of respective control cultures. Representative data of three independent 
experiments. PKC activity (C) in cells of HDC after PKCdelta gene silencing on day 3 of 
culturing. Asterisk indicates significant (*P < 0.01) decrease in enzyme activity as compared 
to the mock-transfected control (day 3). Representative data of 3 independent experiments. 
For panels (A), (B) and (C) cultures treated with the transfection reagent (Lipofectamine 
2000) were used as controls. 
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Figure 6. Protein expression profile and phosphorylation status of Sox9 transcription factor 
and ERK1/2 in HDC during the 6-day-long culturing period. Optical density of signals was 
measured and results were normalised to the optical density of 0-day-old cultures. 
Representative data of 3 independent experiments.  
 
